Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ajinomoto Pharmaceuticals Co. Ltd.

Division of Ajinomoto Co. Inc.

Latest From Ajinomoto Pharmaceuticals Co. Ltd.

Asia Deal Watch: Astellas Looks To Vector Cell Tech From Japan’s RiKen In Oncology

RiKen gets $9.3m up front plus potential milestones and royalties for use of its aAVC technology, while retaining research rights to the platform. JW Pharmaceutical acquires Vietnam’s Euvipharm.

Deals Business Strategies

Deal Watch: United Therapeutics Looks To Extend PAH Dominance With Respira's Combo Product

United will finance clinical development of drug/inhaler device combo with Respira. Takeda offloads more mature products to its joint venture with Teva, and signs a microbiome partnership with Finch Therapeutics.

Deals M & A

New GHIT Funding Supports Novel Malaria, TB Treatments, Diagnostics

Japan's GHIT Fund has made substantial new allocations for malaria and tuberculosis diagnosis and treatment that include extensive pharma industry participation in collaborative research projects.

BioPharmaceutical Medical Device

Eisai Offloads AkaRx To Tighten Therapeutic Focus

Eisai is divesting its AkaRx operation and assets, acquired in 2010, to a health care-focused US private equity group in a move the Japanese firm says will free up resources for its two main therapeutic areas.

BioPharmaceutical Japan
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Ajinomoto Co. Inc.
  • Senior Management
  • Takashi Nagamachi, Pres. & CEO
  • Contact Info
  • Ajinomoto Pharmaceuticals Co. Ltd.
    1-1, Irifune 2-chome
    Tokyo, 104-0042